Morningstar

Comex Silver Ends the Quarter 6.50% Higher at $74.690 — Data Talk

Provided by Dow Jones

Front Month Comex Silver for April delivery gained $4.5560 per troy ounce, or 6.50% to $74.690 this quarter 




     --Up for five consecutive quarters 



     --Up $45.75 or 158.09% over the last five quarters 



     --Longest winning streak since the first quarter of 2011 when the market rose for nine straight quarters 



     --Up nine of the past 10 quarters 



     --This month it is down $17.992 or 19.41% 



     --Largest one month dollar decline since March 1980 



     --Largest one month percentage decline since Sept. 2011 



     --Snaps a 10 month winning streak 



     --Today it is up $4.366 or 6.21% 



     --Largest one day dollar gain since Tuesday, March 10, 2026 



     --Largest one day percentage gain since Friday, Feb. 27, 2026 



     --Up for three consecutive sessions 



     --Up five of the past six sessions 



     --Highest settlement value since Wednesday, March 18, 2026 



     --Off 35.10% from its 52-week high of $115.08 hit Monday, Jan. 26, 2026 



     --Up 156.53% from its 52-week low of $29.116 hit Friday, April 4, 2025 



     --Rose 118.66% from 52 weeks ago 



     --Off 35.10% from its 2026 settlement high of $115.08 hit Monday, Jan. 26, 2026 



     --Up 10.37% from its 2026 settlement low of $67.671 hit Thursday, March 26, 2026 



     --Off 35.10% from its record high of $115.08 hit Monday, Jan. 26, 2026 



     --Year-to-date it is up $4.556 or 6.50% 





     All prices are calculated based on the settlement price of the current front month contract. 





     Source: Dow Jones Market Data, FactSet 





  (END) Dow Jones Newswires



  March 31, 2026 13:55 ET (17:55 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
 
Plus, a deep dive on SpaceX’s bid to challenge US telecoms. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
6 ETFs To Diversify Away From AI
 
A difficult problem has an easy solution. 
 
 
Daniel Sotiroff 
 
 
 
Are TIPS ETFs the Best Way to Fight Inflation?
 
Plus, four TIPS ETFs with top marks from Morningstar, and what you need to know before investing. 
 
 
Daniel Sotiroff and Ivanna Hampton 
 
 
 
What’s Ahead for Stocks This Quarter—and Where to Invest
 
Morningstar’s chief market strategist and economist share their outlooks for the fourth quarter of 2026. 
 
 
David Sekera, CFA, Preston Caldwell, and Susan Dziubinski 
 
 
 
3 New 5-Star Stocks This Week
 
PayPay and CRISPR are now seen as significantly undervalued. 
 
 
Bella Albrecht 
 
 
 
 

			Sponsor Center